Retatrutide remains investigational as of 2026. It isn't FDA-authorized and can't be prescribed or compounded beyond clinical demo participation. Retatrutide is actually a drug that’s now getting made by Eli Lilly for weight loss, sort two diabetes, as well as other conditions. Retatrutide's glucagon agonism seems to counteract this adaptiv